Background-The majority of the literature on catheterization-induced heart block (CIHB) was published >30 years ago.
I njury to the atrioventricular (AV) node is a known complication of cardiac catheterizations. The first report of catheterization-induced heart block (CIHB) in the pediatric population was published in 1966, 1 with only a limited number of studies thereafter focused solely on CIHB. 2, 3 In the meantime, the nature of interventional cardiology has changed, with a greater percentage of patients undergoing catheter-based intervention. 4 The incidence and natural history of CIHB has not been reported in the current era. As pacemakers in the pediatric population can hold significant morbidity, 5 knowledge on the course of AV nodal recovery after catheterization-based injury is important in guiding future therapy. The goals of this study were to determine the incidence of and to identify risk factors of CIHB and the rate at which AV nodal recovery occurs.
Clinical Perspective on p 133
Methods All patients who presented to the cardiac catheterization laboratory at Boston Children's Hospital from July 2005 to August 2011 were included in the study. Patients undergoing electrophysiology studies or hybrid procedures were excluded, as were patients who only had endomyocardial biopsies performed, as they were reported previously. 6 Baseline demographics of the entire study cohort were obtained from a pre-existing database. 7 Variables included history of prior catheterization or surgery and cardiac anatomy divided into the following categories: no structural heart disease (including myopathies), pulmonary hypertension, isolated defects, complex defect with 2 ventricles, and complex defect with 1 ventricle. Hemodynamic parameters previously shown to be independently related with the occurrence of high severity adverse events were also recorded for each patient 7 ( Table 1 , hemodynamic indicators of vulnerability). Procedural characteristics included need for mechanical ventilation, timing of catheterization (elective versus emergent [ie, same day add-on] case) and interventions performed. Case time, contrast dose, fluoroscopy time, and need for inotropic support were also collected as proxy measures of case complexity. Finally, a validated procedure-type risk category score was assigned to each case (categories 1 through 4, with 1 having the lowest and 4 having the highest risk of an adverse event). 8 CIHB was defined as any instance of new-onset complete heart block temporally related to a cardiac catheterization procedure. For these cases, ECG parameters before catheterization were recorded, including the PR interval and QRS duration, as was any history of transient AV block. The duration of heart block was classified as transient (≤10 minutes), resolved before the end of the case, resolved before discharge from the hospital, or did not resolve. Cardiopulmonary resuscitation and the administration of dopamine, epinephrine, isoproterenol, or atropine were noted. Those who received pacemakers were recorded, as well as any subsequent morbidity from having the device implanted. Finally, for CIHB cases, total time spent in the hospital was recorded. Hospitalization because of CIHB was measured from the onset of heart block to (1) return of AV nodal conduction (normal sinus rhythm or first degree AV block) or (2) pacemaker placement.
Procedural consent was obtained before all procedures, including catheterizations and pacemaker placement. The research was approved by the Institutional Review Board at Boston Children's Hospital.
Statistics
Categorical variables were expressed as number (percent) and compared for cases with and without CIHB using Fisher exact test; continuous variables were summarized as median (interquartile range) and compared using the Wilcoxon rank-sum test. Variables significant at the 0.10 level in unadjusted analyses were considered for inclusion in multivariable logistic regression models with the outcome CIHB. The forward selection procedure was used, and a P value <0.05 by the likelihood ratio test was required for retention in the final model. Two separate models were fitted, 1 incorporating preprocedural patient characteristics only, and the other allowing procedural characteristics to enter the model as well. Odds ratios and 95% confidence intervals (CIs) from the final models are presented. The incidence of CIHB is estimated along with a 95% exact binomial confidence interval. The Kaplan-Meier method was used to estimate probability of CIHB by time since injury. Stata version 12.1 was used for all analyses.
Results
During a 6-year study period, a total of 6183 diagnostic or interventional catheterizations were performed at Boston Children's Hospital. There were 135 cases with CIHB (2.2%; 95% confidence interval, 1.9-2.6). Six patients underwent pacemaker placement, 3 of whom recovered conduction. In total, 96% of cases with CIHB recover AV nodal conduction within 1 week. Table 1 summarizes the patient and procedural characteristics of the entire cohort of cases. Twenty-nine percent of cases involved patients <1 year, with a median weight of 15.0 (7.0-47.0) kg. Cases with CIHB were more likely to involve infants (CIHB 51% versus no heart block 29%; P<0.001) and patients that were smaller in size (7.6 versus 15.2 kg; P<0.001).
Patient Characteristics
The majority of cases presenting to the cardiac catheterization laboratory had complex single or 2 ventricle anatomy (72%), with 25% of all cases having a primary diagnosis of single ventricle. Heart block was more likely to occur in cases with complex anatomy, accounting for 87% of all cases with CIHB.
More than half the cases in the cohort had patients with ≥1 hemodynamic indicator of vulnerability, most commonly a low systemic arterial saturation. Of the 4 parameters known to be related to a higher incidence of adverse events, only a mixed-venous saturation <60% was associated with CIHB (CIHB 27% versus no heart block 17%; P=0.03). There was no greater risk of CIHB if >1 hemodynamic indicator of vulnerability was present (P=0.31). A low cardiac index was not associated with heart block (P=1.0).
In general, cases were predominantly performed on an elective basis (76%), on patients on mechanical ventilation (68%), with procedure-risk categories of 1 or 2 (54%). Heart block was associated with more complex cases, with CIHB occurring more in patients with risk categories of 3 or 4 (CIHB 58% versus no heart block 47%; P<0.001), on mechanical ventilation (84% versus 68%; P<0.001), and on inotropic support (53% versus 24%; P<0.001). This was further reflected in the longer case duration of those who had CIHB (>2-hour case: 48% versus 33%; P<0.001), higher contrast dose (4.8 versus 3.6 cc/kg; P<0.001), and longer fluoroscopy time (55 versus 36 minutes; P<0.001).
Interventions were performed in 73% of all cases. Balloon angioplasties were the most commonly performed procedure (46%), often in combination with other interventions. Interventional catheterizations were more likely to experience CIHB (CIHB 81% versus no heart block 71%; P=0.007), but the development of heart block was no different if the cases were performed electively or on a nonelective basis (P=0.07). Balloon angioplasties were the only intervention significantly associated with the development of CIHB (P=0.01). In contrast, CIHB was only noted in 12% of implantable devices (P=1.0), consisting of 7 ventricular septal defect (VSD) devices, 4 atrial septal defect (ASD), 2 Fontan fenestration closures, 2 Melody valves, and 1 left ventricular-to-right atrial shunt. Only 1 VSD closure and the left ventricular-to-right atrial shunt procedure had pacemakers placed.
Reviewing the electrocardiograms of cases that had CIHB, preprocedural intraventricular conduction delay was noted in 42 (31%) cases. The median baseline QRS duration before the catheterization laboratory was 84 (67-105) ms. There was no significant difference in QRS duration between cases that had heart block in the laboratory compared with those who had continued CIHB outside of the laboratory (83 versus 93 ms; P=0.25; 2 cases with transient CIHB were excluded because of missing data).
To determine the risk factors of CIHB, a multivariable analysis was performed using only preprocedural variables 
Outcomes for Patients With Heart Block
Eight patients had 2 episodes of CIHB on separate catheterizations, whereas 1 patient had 3. Transient heart block lasting <10 minutes was noted in 97 (72%) of patients, with another 23 (17%) resolving before the end of the catheterization. Nine patients (7%) recovered AV nodal function before hospital discharge, whereas 6 patients underwent placement of a permanent pacemaker. The 2 patients who had heart block after leaving the catheterization laboratory had intracardiac devices placed (28-mm Amplatzer placed in ASD with CIHB in the recovery room, regained conduction within 12 hours; 23-mm STARFlex placed in left ventricular-to-right atrial shunt with CIHB 4 days post cath, pacemaker placed).
The degree of hemodynamic instability because of heart block was variable. Cardiopulmonary resuscitation was initiated in 21 (16%), 17 of which had recovery of the AV nodal function before discharge from the laboratory. Pharmacological intervention with dopamine, epinephrine, isoproterenol, and atropine was given in 62 (46%) cases, including 13 of the 15 cases that continued to have heart block outside of the catheterization laboratory. Twelve (9%) cases also required temporary transvenous or epicardial pacing, with 3 requiring continued pacing outside of the catheterization laboratory because of inadequate escape rates. Steroids were given in 7 (5%) cases (1 transient CIHB, 4 who resolved before hospital discharge, and 2 who later had pacemakers placed).
Given that CIHB was associated with a mixed-venous saturation <60% but not a low cardiac output, cases with single ventricle physiology after stage I palliation were examined. Of these 15 cases, 4 (27%) had modified Blalock-Taussig shunts, 10 (67%) had Sano conduits, and 1 (6%) was palliated using a hybrid approach. Median age at catheterization was 3.3 (2.7-4.7) months with a weight of 4.6 (4.0-5.4) kg. Transient heart block was noted in 11 (73%) cases: 3 (20%) resolved within 24 hours and 1 (7%) patient with L-looped ventricles had placement of a permanent pacemaker. For the 10 cases with a Stage I Sano, 8 developed heart block while a wire or catheter was crossing the conduit, 1 during balloon dilation of the conduit, and 1 during femoral access.
AV Nodal Recovery
Median follow-up for the CIHB patients was 13.4 (4.1-30.9) months. The majority of CIHB cases (89%) recover AV nodal conduction before leaving the catheterization laboratory ( Figure) . The remaining 15 (11%) cases have variable recovery: 7 cases recovered conduction within 48 hours and another 3 cases within 1 week. There were 2 cases that had late recovery of their AV node (2 and 6 weeks). Overall, 96% of all CIHB patients recover intrinsic conduction within 1 week of injury. Table 4 summarizes the patients who underwent placement of a pacemaker. Three patients had L-looped ventricles, one of whom regained conduction after CIHB. Two patients had intracardiac devices placed. All the patients who underwent pacemaker placement experienced heart block within the catheterization laboratory, except for patient #1. This patient had a device closure of a left ventricular-to-right atrial shunt and had first degree AV block during the catheterization. This later progressed to complete heart block 4 days after the catheterization, resulting in pacemaker insertion 2 days later.
Hospitalization for Patients With Heart Block
Of the cases with CIHB, 94 (69%) were performed on an elective basis, with 33 performed on patients already admitted to the hospital. The remainder of the cases were performed on a nonelective basis and came from the ICU (n=31), inpatient cardiac floor (n=7), or other locations (n=3), including the emergency room. Six cases resulted in patients being sent home the same day. The median time for hospital stay post catheterization was 3 days (range, 0-289 days). Only 14 (10%) had inpatient days attributed solely to heart block. The 8 cases with CIHB resolving before discharge had patients who stayed in the hospital a median of 2 extra days, with 5 requiring monitoring in the cardiac ICU. Of the patients who had pacemakers placed, 1 remained in the cardiac ICU the length of their admission (60 days), only partially attributed to CIHB, whereas the other 5 had a median admission of 10 (range 7-15) days, with a median of 7 days in the cardiac ICU (range 2-15).
Discussion
The incidence of CIHB in the modern era continues to be low at 2.2%. The great majority of these CIHB cases regained conduction before the end of catheterization, with only a small number of patients undergoing pacemaker placement. This is the first report examining the risk factors of CIHB and the timing of AV nodal recovery after catheter injury. Independent risk factors of CIHB include young age and long case duration. Catheter selection and maneuverability can be limited in younger patients and may explain the increased likelihood of CIHB by 4 to 5× in patients <1 year. Cases longer than 2 hours had a 3-fold increase in CIHB, unrelated to whether an intervention was performed. Prolonged cases, with catheters being exchanged and manipulated, are inherently more at risk for inadvertent AV nodal injury.
To better prepare catheterization laboratories for potential CIHB, a second multivariable model was created, using variables that could reasonably be known before a case was started. From this, patients <1 year, mechanical ventilation, complex anatomy (single or 2 ventricle hearts with more than isolated defects), and interventional catheterizations were identified as risk factors of CIHB. Having inotropes and transvenous pacing ready at the onset of the procedure would be recommended for these higher risk patients. Given that the majority of CIHB is transient in nature, a rapid response toward supporting the patient's circulation while awaiting return of AV nodal conduction may reduce long-term morbidity and limit the resources needed in caring for these patients post catheterization. Steroids may also be considered to treat heart block, although the literature is currently limited to case reports looking at the use of steroids and aspirin in reversing mechanical AV block. 9, 10 Although no apparent harm was noted with steroid administration, only 7 CIHB patients were treated (with 5 regaining conduction and 2 requiring permanent pacing), limiting significant conclusions from being drawn on the efficacy of steroids for treating CIHB.
It was interesting to note that a mixed-venous saturation <60% was a univariable risk factor for CIHB but not a low cardiac index. This may reflect the patients with single ventricle physiology presenting to the catheterization laboratory. Previous case reports have found both transient and permanent complete heart block in patients after stenting of Sano conduits. 11, 12 In our study, 10 patients with Sano conduits developed CIHB, 8 with catheter manipulation only. The orientation of the Sano conduit may place patients at higher risk for heart block. With the distal anastomosis often rightward of the pulmonary artery bifurcation, a catheter from the inferior vena cava may cause a loop to push against the ventricular septum, mechanically irritating the conduction system. With the increase in Sano conduits versus modified Blalock-Taussig shunts, 13 physicians should have an increased awareness of the potential for CIHB in these patients.
Patients with intracardiac devices also warrant closer monitoring for AV nodal injury. 9, 10 The incidence of heart block after ASD or VSD closure has been reported at ≈3% to 6%. 10, 14 In general, devices placed near the crux of the heart have an increased risk for CIHB, because of the risk of friction against the conduction tissues. Moreover, CIHB can occur late. Similar to our study, Tao et al 10 reported late occurrence of heart block after placement of an intracardiac device. This relatively late development of heart block may be because of the shape memory of these devices, 15 allowing them to reconfigure within the heart. This restructuring of the devices can lead to endocardial injury over time, and in some cases, inflame or erode conduction tissue. Patients should be monitored closely after device placement, with ECGs performed before discharge and at follow-up.
In this series, 8% of the patients who had CIHB required monitoring within the cardiac ICU and 4% ultimately underwent placement of a permanent pacemaker. Given the morbidity that can be associated with pacemaker insertion, 5, 16 it is important to determine when a device should be placed. Our data found that 96% of CIHB resolved within the first 7 days, which is in keeping with the surgical heart block experience. 17 Given the retrospective nature of our study, markers for AV nodal recovery could not be assessed for CIHB patients. Thus, although 50% of CIHB patients with pacemakers eventually recovered conduction, given the inability to predict AV nodal recovery in these patients, 1 week may be a reasonable period of observation before pacemaker implantation.
Interestingly, the mechanism of CIHB in the pediatric catheterization laboratory seems to differ from that in adult studies. 3, 18, 19 In contrast to adults, pre-existing right or left bundle-branch block was not common in pediatric patients who developed more than transient CIHB. This would indicate that AV block in our population is not caused by injury to both the right and the left fascicle, but direct injury to the compact node or bundle of His. It is not surprising then that L-looped ventricles, known to be prone to heart block because of their abnormally positioned AV node and long penetrating bundle, 20 made up half of the patients who underwent permanent pacemaker placement.
Cases that did not have CIHB were identified from a pre-existing database, with data limited to patient and procedural characteristics previously recorded. This resulted in a heterogeneous patient population being categorized into more general fields (ie, complex 1 or 2 ventricle anatomy), restricting our risk factor analysis to those already defined within the database itself. The majority of our cases also had transient heart block; as a result, the small number of patients who required permanent pacemakers limited our ability to determine risk factors of significant long-term CIHB. Details such as the exact catheter course resulting in heart block were also not recorded. Despite these limitations, this study is the first to report on CIHB and may be useful in guiding further investigations on this important complication.
In conclusion, CIHB is a rare complication in the pediatric cardiac catheterization laboratory, with infants and those undergoing prolonged procedures being at highest risk. Although the majority of CIHB is transient in nature, back-up pacing systems should be readily available to support the patient through the potentially hemodynamically compromising event. The recovery time from CIHB seems to be similar to that reported for of surgically induced heart block in patients with congenital heart disease, with most patients regaining conduction during the course of a week.
